Cargando…

Neuraminidase-1 promotes heart failure after ischemia/reperfusion injury by affecting cardiomyocytes and invading monocytes/macrophages

Neuraminidase (NEU)1 forms a multienzyme complex with beta-galactosidase (β-GAL) and protective-protein/cathepsin (PPC) A, which cleaves sialic-acids from cell surface glycoconjugates. We investigated the role of NEU1 in the myocardium after ischemia/reperfusion (I/R). Three days after inducing I/R,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heimerl, Maren, Sieve, Irina, Ricke-Hoch, Melanie, Erschow, Sergej, Battmer, Karin, Scherr, Michaela, Hilfiker-Kleiner, Denise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Contribution
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519006/ https://www.ncbi.nlm.nih.gov/pubmed/32975669 http://dx.doi.org/10.1007/s00395-020-00821-z

Ejemplares similares

Anthracycline-free tumor elimination in mice leads to functional and molecular cardiac recovery from cancer-induced alterations in contrast to long-lasting doxorubicin treatment effects
por: Pietzsch, Stefan, et al.
Publicado: (2021)

Increased prostaglandin-D(2) in male STAT3-deficient hearts shifts cardiac progenitor cells from endothelial to white adipocyte differentiation
por: Stelling, Elisabeth, et al.
Publicado: (2020)

Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia
por: Scherr, Michaela, et al.
Publicado: (2018)

Chemotherapy-Free Targeted Anti-BCR-ABL+ Acute Lymphoblastic Leukemia Therapy May Benefit the Heart
por: Kirchhoff, Hanna, et al.
Publicado: (2022)

Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion
por: Boengler, Kerstin, et al.
Publicado: (2010)

Neuraminidases—Key Players in the Inflammatory Response after Pathophysiological Cardiac Stress and Potential New Therapeutic Targets in Cardiac Disease
por: Heimerl, Maren, et al.
Publicado: (2022)

Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy
por: Pfeffer, Tobias J., et al.
Publicado: (2022)

Inhibition of cardiomyocyte Sprouty1 protects from cardiac ischemia–reperfusion injury
por: Alakoski, Tarja, et al.
Publicado: (2019)

Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy
por: Stapel, Britta, et al.
Publicado: (2017)

Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental peripartum cardiomyopathy
por: Pfeffer, Tobias J., et al.
Publicado: (2021)

miR-125b regulates chemotaxis and survival of bone marrow derived granulocytes in vitro and in vivo
por: Lee, Chun-Wei, et al.
Publicado: (2018)

Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion
por: Obal, Detlef, et al.
Publicado: (2012)

Differential expression of miR-17∼92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia
por: Scherr, M, et al.
Publicado: (2014)

Data on left ventricular expression of STAT3 and AKT in transgenic mouse models with B16F10 melanoma
por: Pietzsch, Stefan, et al.
Publicado: (2019)

Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy
por: Nonhoff, Justus, et al.
Publicado: (2017)

Human iPSC-Derived Cardiomyocytes of Peripartum Patients With Cardiomyopathy Reveal Aberrant Regulation of Lipid Metabolism
por: Hoes, Martijn F., et al.
Publicado: (2020)

Cardiomyocytes display low mitochondrial priming and are highly resistant toward cytotoxic T‐cell killing
por: Zheng, Xiang, et al.
Publicado: (2016)

Elevated platelet–leukocyte complexes are associated with, but dispensable for myocardial ischemia–reperfusion injury
por: Starz, Christopher, et al.
Publicado: (2022)

Acute NADPH oxidase activation potentiates cerebrovascular permeability response to bradykinin in ischemia–reperfusion
por: Woodfin, Abigail, et al.
Publicado: (2011)

Multilineage contribution of CD34(+) cells in cardiac remodeling after ischemia/reperfusion injury
por: Xie, Jun, et al.
Publicado: (2023)

Exercise-induced peptide TAG-23 protects cardiomyocytes from reperfusion injury through regulating PKG–cCbl interaction
por: Cheng, Zijie, et al.
Publicado: (2021)

Protection against cardiac ischemia-reperfusion injury by hypothermia and by inhibition of succinate accumulation and oxidation is additive
por: Kohlhauer, M., et al.
Publicado: (2019)

Critical Role of Flavin and Glutathione in Complex I–Mediated Bioenergetic Failure in Brain Ischemia/Reperfusion Injury
por: Kahl, Anja, et al.
Publicado: (2018)

Cardioprotective Effects of Quercetin in Cardiomyocyte under Ischemia/Reperfusion Injury
por: Chen, Yi-Wen, et al.
Publicado: (2013)

Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion
por: Zalewski, Jaroslaw, et al.
Publicado: (2015)

Uncoupling protein 3 deficiency impairs myocardial fatty acid oxidation and contractile recovery following ischemia/reperfusion
por: Edwards, Kristin S., et al.
Publicado: (2018)

Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapy
por: Hoch, Melanie, et al.
Publicado: (2011)

Effects of procyanidin on cardiomyocyte apoptosis after myocardial ischemia reperfusion in rats
por: Liu, Dan
Publicado: (2018)

Targeting MIAT reduces apoptosis of cardiomyocytes after ischemia/reperfusion injury
por: Chen, Longying, et al.
Publicado: (2019)

Pre-conditioning with synthetic CpG-oligonucleotides attenuates myocardial ischemia/reperfusion injury via IL-10 up-regulation
por: Markowski, P., et al.
Publicado: (2013)

Homozygous Smpd1 deficiency aggravates brain ischemia/ reperfusion injury by mechanisms involving polymorphonuclear neutrophils, whereas heterozygous Smpd1 deficiency protects against mild focal cerebral ischemia
por: Hagemann, Nina, et al.
Publicado: (2020)

Protective effect of HINT2 on mitochondrial function via repressing MCU complex activation attenuates cardiac microvascular ischemia–reperfusion injury
por: Li, Su, et al.
Publicado: (2021)

Exploring metapopulation‐scale suppression alternatives for a global invader in a river network experiencing climate change
por: Healy, Brian D., et al.
Publicado: (2022)

Autocrine effects of PCSK9 on cardiomyocytes
por: Wolf, Annemarie, et al.
Publicado: (2020)

Human embryonic stem cell-derived cardiomyocyte therapy in mouse permanent ischemia and ischemia-reperfusion models
por: Yu, You, et al.
Publicado: (2019)

Impairment of Endothelial-Myocardial Interaction Increases the Susceptibility of Cardiomyocytes to Ischemia/Reperfusion Injury
por: Leucker, Thorsten M., et al.
Publicado: (2013)

Resveratrol Attenuates Ischemia/Reperfusion Injury in Neonatal Cardiomyocytes and Its Underlying Mechanism
por: Shen, Min, et al.
Publicado: (2012)

Effects of Shenmai injection and its bioactive components following ischemia/reperfusion in cardiomyocytes
por: YE, LI-FANG, et al.
Publicado: (2015)

Protective effects of fentanyl preconditioning on cardiomyocyte apoptosis induced by ischemia-reperfusion in rats
por: Xu, Q., et al.
Publicado: (2017)

Cardiomyocyte Damage: Ferroptosis Relation to Ischemia-Reperfusion Injury and Future Treatment Options
por: Laukaitiene, Jolanta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h00bhblpqcrfnmcmpptva3qpag